Image Quality and Lesion Detectability of Low-Concentration Iodine Contrast and Low Radiation Hepatic Multiphase CT Using a Deep-Learning-Based Contrast-Boosting Model in Chronic Liver Disease Patients

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2024 Oct 25

PMID 39451631

Authors

Yewon Lim

Jin Sil Kim

Hyo Jeong Lee

Jeong Kyong Lee

Hye Ah Lee

Chulwoo Park

Affiliations

Soon will be listed here.

Abstract

Background: This study investigated the image quality and detectability of double low-dose hepatic multiphase CT (DLDCT, which targeted about 30% reductions of both the radiation and iodine concentration) using a vendor-agnostic deep-learning-based contrast-boosting model (DL-CB) compared to those of standard-dose CT (SDCT) using hybrid iterative reconstruction.

Methods: The CT images of 73 patients with chronic liver disease who underwent DLDCT between June 2023 and October 2023 and had SDCT were analyzed. Qualitative analysis of the overall image quality, artificial sensation, and liver contour sharpness on the arterial and portal phase, along with the hepatic artery clarity was conducted by two radiologists using a 5-point scale. For quantitative analysis, the image noise, signal-to-noise ratio, and contrast-to-noise ratio were measured. The lesion conspicuity was analyzed using generalized estimating equation analysis. Lesion detection was evaluated using the jackknife free-response receiver operating characteristic figures-of-merit.

Results: Compared with SDCT, a significantly lower effective dose (16.4 ± 7.2 mSv vs. 10.4 ± 6.0 mSv, 36.6% reduction) and iodine amount (350 mg iodine/mL vs. 270 mg iodine/mL, 22.9% reduction) were utilized in DLDCT. The mean overall arterial and portal phase image quality scores of DLDCT were significantly higher than SDCT (arterial phase, 4.77 ± 0.45 vs. 4.93 ± 0.24, AUC 0.572 [95% CI, 0.507-0.638]; portal phase, 4.83 ± 0.38 vs. 4.92 ± 0.26, AUC 0.535 [95% CI, 0.469-0.601]). Furthermore, DLDCT showed significantly superior quantitative results for the lesion contrast-to-noise ratio (7.55 ± 4.55 vs. 3.70 ± 2.64, < 0.001) and lesion detectability (0.97 vs. 0.86, = 0.003).

Conclusions: In patients with chronic liver disease, DLDCT using DL-CB can provide acceptable image quality without impairing the detection and evaluation of hepatic focal lesions compared to SDCT.

References

Chernyak V, Fowler K, Kamaya A, Kielar A, Elsayes K, Bashir M . Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018; 289(3):816-830. PMC: 6677371. DOI: 10.1148/radiol.2018181494. View

Park J, Shin J, Min I, Bae H, Kim Y, Chung Y . Image Quality and Lesion Detectability of Lower-Dose Abdominopelvic CT Obtained Using Deep Learning Image Reconstruction. Korean J Radiol. 2022; 23(4):402-412. PMC: 8961013. DOI: 10.3348/kjr.2021.0683. View

Shin Y, Chang W, Ye J, Kang E, Oh D, Lee Y . Low-Dose Abdominal CT Using a Deep Learning-Based Denoising Algorithm: A Comparison with CT Reconstructed with Filtered Back Projection or Iterative Reconstruction Algorithm. Korean J Radiol. 2020; 21(3):356-364. PMC: 7039719. DOI: 10.3348/kjr.2019.0413. View

Martino F, Amici G, Rosner M, Ronco C, Novara G . Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: The Physio-Pathological Conditions for the Perfect Murder. J Clin Med. 2021; 10(2). PMC: 7828445. DOI: 10.3390/jcm10020271. View

Fahling M, Seeliger E, Patzak A, Persson P . Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol. 2017; 13(3):169-180. DOI: 10.1038/nrneph.2016.196. View

Tsurusaki M, Sugimoto K, Fujii M, Sugimura K . Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT--a prospective randomized study. Radiat Med. 2004; 22(4):239-45. View

Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M . Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017; 67(2):302-309. DOI: 10.1016/j.jhep.2017.03.011. View

Park S, Kang D, Sohn K, Yoon S, Lee W, Choi Y . Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids. Radiology. 2018; 288(3):710-716. DOI: 10.1148/radiol.2018172524. View

Lee T, Yoon J, Park J, Lee J, Choi J, Ahn C . Deep learning-based iodine contrast-augmenting algorithm for low-contrast-dose liver CT to assess hypovascular hepatic metastasis. Abdom Radiol (NY). 2023; 48(11):3430-3440. DOI: 10.1007/s00261-023-04039-0. View

10.

Seeliger E, Lenhard D, Persson P . Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies. Biomed Res Int. 2014; 2014:358136. PMC: 3950904. DOI: 10.1155/2014/358136. View

11.

Landis J, Koch G . The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. View

12.

Bath M, Hansson J . VGC ANALYZER: A SOFTWARE FOR STATISTICAL ANALYSIS OF FULLY CROSSED MULTIPLE-READER MULTIPLE-CASE VISUAL GRADING CHARACTERISTICS STUDIES. Radiat Prot Dosimetry. 2016; 169(1-4):46-53. DOI: 10.1093/rpd/ncv542. View

13.

Shin D, Choi Y, Lee S, Cho Y, Lee S, Cheon J . Low-iodine-dose computed tomography coupled with an artificial intelligence-based contrast-boosting technique in children: a retrospective study on comparison with conventional-iodine-dose computed tomography. Pediatr Radiol. 2024; 54(8):1315-1324. PMC: 11254996. DOI: 10.1007/s00247-024-05953-1. View

14.

Bae J, Lee J, Kim S, Park S, Han S, Yoon J . Low-contrast-dose liver CT using low monoenergetic images with deep learning-based denoising for assessing hepatocellular carcinoma: a randomized controlled noninferiority trial. Eur Radiol. 2022; 33(6):4344-4354. DOI: 10.1007/s00330-022-09298-x. View

15.

Lee D, Lee J, Lee C, Afat S, Othman A . Image Quality and Diagnostic Performance of Low-Dose Liver CT with Deep Learning Reconstruction versus Standard-Dose CT. Radiol Artif Intell. 2024; 6(2):e230192. PMC: 10982822. DOI: 10.1148/ryai.230192. View

16.

Lameire N . Contrast-induced nephropathy--prevention and risk reduction. Nephrol Dial Transplant. 2006; 21(6):i11-23. DOI: 10.1093/ndt/gfl215. View

17.

Namasivayam S, Kalra M, Torres W, Small W . Adverse reactions to intravenous iodinated contrast media: an update. Curr Probl Diagn Radiol. 2006; 35(4):164-9. DOI: 10.1067/j.cpradiol.2006.04.001. View

18.

Lee H, Kim J, Lee J, Lee H, Pak S . Ultra-low-dose hepatic multiphase CT using deep learning-based image reconstruction algorithm focused on arterial phase in chronic liver disease: A non-inferiority study. Eur J Radiol. 2022; 159:110659. DOI: 10.1016/j.ejrad.2022.110659. View

19.

Kang H, Lee J, Ahn C, Bae J, Han S, Kim S . Low dose of contrast agent and low radiation liver computed tomography with deep-learning-based contrast boosting model in participants at high-risk for hepatocellular carcinoma: prospective, randomized, double-blind study. Eur Radiol. 2023; 33(5):3660-3670. DOI: 10.1007/s00330-023-09520-4. View

20.

Choi E, Kim J, Lee J, Lee H, Pak S . Prospective evaluation of low-dose multiphase hepatic computed tomography for detecting and characterizing hepatocellular carcinoma in patients with chronic liver disease. BMC Med Imaging. 2022; 22(1):219. PMC: 9762112. DOI: 10.1186/s12880-022-00947-7. View